LabGenius and Sanofi launch AI-driven collaboration on antibody optimisation

Mitsubishi Tanabe Pharma America changes name

Sanofi and Regeneron's Dupixent approved in EU for chronic spontaneous urticaria

Xenogenic Materials Demonstrate Promising Results in Peri-Implantitis Management

European Commission approves Insmed's BRINSUPRI for the treatment of non-cystic fibrosis bronchiectasis

European Commission approves Celltrion's Remsima IV liquid formulation

Biotheryx completes enrolment in ongoing Phase 1a trial of BTX-9341 for HR+/HER2- breast cancer

Henlius and Organon secure first US approval for pertuzumab biosimilar POHERDY

CHMP issues positive opinion for DAWNZERA in hereditary angioedema

Longeveron secures US patent for stem cell therapy targeting aging-related frailty

ABIONYX Pharma advances strategic alliance talks with IHU SEPSIS to build global sepsis innovation platform

Mabwell receives NMPA approval to begin Phase II trial for IL-11-targeting drug for pathological scarring

Vascarta and CUNY report positive preclinical results in glioblastoma treatment

Akeso reveals preclinical research data for novel antagonistic monoclonal antibody aimed at IL-1RAP (AK135)

Sanofi and Regeneron's Dupixent meets all endpoints in pivotal AFRS study; sBLA accepted for FDA priority review